# Editorial: Lipids, lipid oxidation, and cancer: from biology to therapeutics

Sergio P Bydlowski, Marc Poirot

► To cite this version:

Sergio P Bydlowski, Marc Poirot. Editorial: Lipids, lipid oxidation, and cancer: from biology to therapeutics. Frontiers in Oncology, 2024, 14, pp.1414992. 10.3389/fonc.2024.1414992. inserm-04772050

HAL Id: inserm-04772050

https://inserm.hal.science/inserm-04772050v1

Submitted on 7 Nov 2024

HAL is a multi-disciplinary open access
archive for the deposit and dissemination of sci-
entific research documents, whether they are pub-
lished or not. The documents may come from
teaching and research institutions in France or
abroad, or from public or private research centers.

L'archive ouverte pluridisciplinaire HAL, est
destinée au dépôt et à la diffusion de documents
scientifiques de niveau recherche, publiés ou non,
émanant des établissements d'enseignement et de
recherche français ou étrangers, des laboratoires
publics ou privés.

<figure><img src="image_1.png" /></figure>
<figure><img src="image_2.png" /></figure>

Check for updates

OPEN ACCESS

EDITED AND REVIEWED BY
Tao Liu,
University of New South Wales, Australia

*CORRESPONDENCE

Sergio P. Bydlowski

<figure><img src="image_3.png" /></figure>

spbydlow@usp.br

Marc Poirot

<figure><img src="image_4.png" /></figure>

marc.poirot@inserm.fr

RECEIVED 09 April 2024

ACCEPTED 12 April 2024

PUBLISHED 19 April 2024

CITATION

Bydlowski SP and Poirot M (2024) Editorial: Lipids, lipid oxidation, and cancer: from biology to therapeutics.
*Front. Oncol.* **14**:1414992.
doi: 10.3389/fonc.2024.1414992

COPYRIGHT

© 2024 Bydlowski and Poirot. This is an open-
access article distributed under the terms of
the Creative Commons Attribution License
(CC BY). The use, distribution or reproduction
in other forums is permitted, provided the
original author(s) and the copyright owner(s)
are credited and that the original publication
in this journal is cited, in accordance with
accepted academic practice. No use,
distribution or reproduction is permitted
which does not comply with these terms.

Editorial: Lipids, lipid oxidation,
and cancer: from biology
to therapeutics

Sergio P. Bydlowski<fnref n="1" />,²,<fnref n="3" />* and Marc Poirot⁴,<fnref n="5" />*

KEYWORDS

lipids, lipid oxidation, lipoprotein, cancer, immune cells, fatty acid, triple-negative breast cancer, HPV

Editorial on the Research Topic

Lipids, lipid oxidation, and cancer: from biology to therapeutics

From fatty acids, the most fundamental biological lipid, glycerolipids, phospholipids, and sphingolipids, to lipoproteins and steroid molecules such as cholesterol, oxysterols, vitamin D, lipids all have distinct and multiple biological activities and functions. Several lipid metabolic aspects such as biosynthesis, oxidation, uptake, enzymes, regulation, signaling pathways, have been shown to be implicated in several diseases, including cancer.

In fact, lipids are crucial in the pathophysiology of cancer development. Several types of cancers share common alterations in the complex cell lipid metabolism. These dysregulated changes can affect several physiological characteristics of cells such as membrane synthesis, energy homeostasis, post-translational protein modifications, and cell signaling, thus sustaining cell growth, proliferation, differentiation, and survival (1-6), the most prominent features of cancer cells, as is evident by the articles in this topic.

The work of Duong et al. provides a review of the state of the art in lipid metabolism in tumor immunology. Lipids are an important source of energy for rapidly proliferating cells. Lipids also affect the immune system and its components in a variety of ways. Accumulation of lipids in the tumor microenvironment has been shown to promote immune evasion and inflammation In fact, abnormal lipid accumulation in tumors correlates with T-cell dysfunction, T-cell exhaustion, increased proportions of regulatory T cells and memory T cells, and increased T-cell recall responses.

The authors addressed the importance of lipid metabolism by describing the action of lipids and lipid oxidation in 1. Immune cells (T cells, macrophages, natural killer cells, dendritic cells); 2. The proliferation and survival of cancer cells; 3. Cancer progression and angiogenesis (overview of lipid metabolism, role of lipid metabolism in cancer); 4. Cancer metastasis; and 5. Cancer immunotherapy (lipids as adjuvants, lipids as vehicles, role of lipids in immune responsiveness.

<footnote n="1">¹Lipids, Oxidation and Cell Biology Team, Laboratory of Immunology (LIM19), Heart Institute (InCor), Faculdade de Medicina, Universidade de São Paulo, Sao Paulo, Brazil, ²Department of Hematology, Hemotherapy and Cell Therapy, Faculdade de Medicina, Universidade de São Paulo, Sao Paulo, Brazil,</footnote>

<footnote n="3">³National Institute of Science and Technology in Regenerative Medicine (INCT-Regenera), CNPq, Rio de Janeiro, Brazil, ⁴Cancer Research Center of Toulouse (CRCT), Inserm, CNRS, University of Toulouse III, Team INOV: "Cholesterol Metabolism and Therapeutic Innovations", Toulouse, France,</footnote>

<footnote n="5">⁵French Network for Nutrition Physical Activity and Cancer Research (NACRe Network), Jouy-en-Josas, France</footnote>
Triple-negative breast cancer (TNBC) accounts for 10-20% of all breast cancer. It is negative for hormone receptors (estrogen, progesterone) and HER-2. Changes in plasma lipid and lipoprotein profiles contributes to BC, considering the role of lipids, particularly cholesterol, in tumor proliferation and metastasis (7, 8). Campos et al. describes that HDL retards LDL oxidation by 22% in the plasma of TNBC patients as compared to the control group and this is positively correlated with apoA-I content in HDL. Moreover, the antioxidant activity of HDL was greater in the advanced stages of TNBC. The findings highlight the role of HDL as an antioxidant defense in limiting oxidative and inflammatory stress in advanced stages of TNBC.

The next two articles are related to the effects of Human Papilloma Virus (HPV). The main cause of preinvasive or invasive cervical cancer is infection with HPV. Loss of apoptotic control allows cancer cells to survive longer, increasing both, the time for mutation accumulation and the ability to invade during tumor development. After infection, HPV encodes proteins E6 and E7 which together promote cell proliferation, prolong cell cycle progression, and prevent apoptosis (9, 10). E6 and E7 initiate oncogenesis through interactions with tumor suppressor genes -TP53 for E6 and retinoblastoma protein for E7 (11).

Liu et al. findings are related to the metabolic heterogeneity in cervical cancer cell lines C33A and CaSki, evaluated by multiomics analysis. The differential metabolites were screened, and functional enrichment and pathway analysis were performed. Association analysis was carried out with transcriptomics, and the important differential metabolisms were analyzed by real-time PCR. The findings showed differences in amino acids, nucleotides and lipids (such as threonine, arachidonic acid and hypoxanthine) in the metabolic pathways between the C33A and CaSki cell lines. C33A cells exhibited higher contents of fatty acid polar derivatives, while CaSki cells showed higher contents of free fatty acids and glycerides. The findings suggest that p53 and the genes involved in lipid metabolism pathways, such as PPARG and SCD, are relevant to the metabolic heterogeneity of the cells. In summary, their results showed that the metabolomic differences between C33A and CaSki cells might be related to the decreased expression of PPARG and p53 caused by HPV E6.

The work by Permatasari et al. aimed to evaluate the anticancer activity of *Caulerpa racemosa* on HeLa cervical cancer cells. Natural sources, especially underutilized marine products, have promising potential as functional food or nutraceutical with anticancer properties. In fact, natural marine products, as sea grapes, have been used as compounds for drug discovery. They are frequently used as drugs (antiageing, antidiabetic, antirheumatism). Sea grapes is a term for varieties of green seaweed of the genus Caulerpa (12). Caulerpa has bioactive metabolites (alkaloids, terpenoids, flavonoids, steroids and tannins) and its bioactivity has been reported against cancer (13). This article describes that *C. racemosa* extract significantly increases the expression of pro-apoptotic proteins BAX and cleaves caspase-3. Annexin V-PI induced apoptosis in treated cells and decreased HeLa cell viability at 24 h and 48 h post-treatment. There has been no research up to now on the benefits of *C. racemosa* originating

from Indonesia. The potential of this *C. racemosa* as an anticancer by inhibiting antiapoptosis (Bcl-2), increasing proapoptosis (BAX) and cleaved caspase-3 *in vitro* is here described for the first time.

In the opinion article discussing the combination of green seaweed's fatty acids and heterocyclic derivatives as anticancer nutraceuticals by Taher et al., they discuss the future implication and direction of this application. Green seaweed has fatty acid content that makes up most of its fat content. The incorporation of heterocyclic compounds into fatty acids are proposed to increase the anticancer cytotoxicity and efficacy of cancer therapeutic agents. Therefore, green seaweeds would have their potential as anticancer nutraceuticals.

Finally, in the last article (14), Nurkolis et al. proposed the soy-based tempe as part of a future meal by its anti cancer potential. In fact, a diet high in soy has been associated with a lower prevalence of several types of cancer (14). Tempe, a soy-based fermented food originating from Indonesia, is reported to be capable of inhibiting proliferation and angiogenesis as well as triggering apoptosis in cancer cells (15). This opinion paper presents updated evidence about the anticancer potential of soy-based tempe and the possibility of its use as a functional meal.

In conclusion, the articles that comprise this Research Topic highlight several key roles that lipids can play in several aspects of cancer and address ongoing and future challenges.

## Author contributions

SB: Conceptualization, Formal analysis, Supervision, Writing – original draft, Writing – review & editing. MP: Conceptualization, Formal analysis, Supervision, Writing – original draft, Writing – review & editing.

## Acknowledgments

We thank the authors, reviewers, and editors, for their invaluable contributions and efforts that have greatly enriched this Topic.

## Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

## Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References

1. Levy D, Correa de Melo T, Ohira BY, Fidelis ML, Ruiz JLM, Rodrigues A, et al. Oxysterols selectively promote short-term apoptosis in tumor cell lines. *Biochem Biophys Res Commun.* (2018) 505:1043–49. doi: 10.1016/j.bbrc.2018.10.008

2. de Freitas FA, Levy D, Zarrouk A, Lizard G, Bydlowski SP. Impact of oxysterols on cell death, proliferation, and differentiation induction: current status. *Cells*. (2021) 10:2301. doi: 10.3390/cells10092301

3. de Freitas FA, Levy D, Reichert CO, Cunha-Neto E, Kalil J, Bydlowski SP. Effects of oxysterols on immune cells and related diseases. *Cells*. (2022) 11:1251. doi: 10.3390/cells11081251

4. Ben Hassen C, Goupille C, Vigor C, Durand T, Guéraud F, Silvente-Poirot S, et al. Is cholesterol a risk factor for breast cancer incidence and outcome? *J Steroid Biochem Mol Biol.* (2023) 232:106346. doi: 10.1016/j.jsbmb.2023.106346

5. de Médina P, Ayadi S, Soulès R, Payre B, Rup-Jacques S, Silvente-Poirot S, et al. Chemical synthesis and biochemical properties of cholestane-5α,6β-diol-3-sulfonate: A non-hydrolysable analogue of cholestane-5α,6β-diol-3β-sulfate. *J Steroid Biochem Mol Biol.* (2023) 234:106396. doi: 10.1016/j.jsbmb.2023.106396

6. de Medina P, Ayadi S, Diallo K, Buñay J, Pucheu L, Soulès R, et al. The cholesterol-5,6-epoxide hydrolase: A metabolic checkpoint in several diseases. *Adv Exp Med Biol.* (2024) 1440:149–61. doi: 10.1007/978-3-031-43883-7_8

7. Guan X, Liu Z, Zhao Z, Zhang X, Tao S, Yuan B, et al. Emerging roles of lowdensity lipoprotein in the development and treatment of breast cancer. *Lipids Health Dis.* (2019) 18:137. doi: 10.1186/s12944-019-1075-7

8. Wei Y, Huang Y, Yang W, Huang K, Chen Y, Zeng K, et al. The significances and clinical implications of cholesterol components in human breast cancer. *Sci Prog.* (2021) 104:368504211028395. doi: 10.1177/00368504211028395

9. Chan CK, Aimagambetova G, Ukybassova T, Kongrtay K AA. Human papillomavirus infection and cervical cancer: Epidemiology, screening, and vaccination - review of current perspectives. *J Oncol.* (2019) 2019:3257939. doi: 10.1155/2019/3257939

10. DeFilippis RA, Goodwin EC, Wu L, DiMaio D. Endogenous human papillomavirus E6 and E7 proteins differentially regulate proliferation, senescence, and apoptosis in HeLa cervical carcinoma cells. *J Virol.* (2003) 77:1551–63. doi: 10.1128/JVI.77.2.1551-1563.2003

11. Granados-Loipez AJ, Manzanares-Acuña E, Loipez-Hernández Y, Castañeda Delgado JE, Fraire-Soto I, Reyes-Estrada CA, et al. Uvb inhibits proliferation, cell cycle and induces apoptosis via p53, e2f1 and microtubules system in cervical cancer cell lines. *Int J Mol Sci.* (2021) 22:1–14. doi: 10.3390/ijms22105197

12. Paul NA, Neveux N, Magnusson MNR. Comparative production and nutritional value of “sea grapes” - the tropical green seaweeds caulerpa lentillifera and c. racemosa. *J Appl Phycol.* (2014) 26:1833–44. doi: 10.1007/s10811-013-0227-9

13. Permatasari HK, Bulain S, Amar N, Azizah MR, Muslim FZ, Daud VPA, et al. Anticancer properties of caulerpa racemosa: A review study. *Nutr Clin y Diet Hosp.* (2022) 42:110–21. doi: 10.12873/423permatasari

14. Kucuk O. Soy foods, isoflavones, and breast cancer. *Cancer*. (2017) 123:1901–3. doi: 10.1002/cncr.30614

15. Bintari SH, Nugraheni K. The potential of tempeh as a chemopreventive and chemotherapeutic agent targeting breast cancer cells. *Pakistan J Nutr.* (2017) 16:743–9. doi: 10.3923/pjn.2017.743.749